首页>
外国专利>
5--N-5S-2--3-4-56--4H-124-1--13--5--2- NOVEL CRYSTALLINE FORM OF 5-CHLORO-N-5S-2-OXO-3-4-56-DIHYDRO-4H-124TRIAZIN-1-YLPHENYL-13-OXAZOLIDIN-5-YLMETHYLTHIOPHENE-2-CARBOXAMIDE METHANESULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
5--N-5S-2--3-4-56--4H-124-1--13--5--2- NOVEL CRYSTALLINE FORM OF 5-CHLORO-N-5S-2-OXO-3-4-56-DIHYDRO-4H-124TRIAZIN-1-YLPHENYL-13-OXAZOLIDIN-5-YLMETHYLTHIOPHENE-2-CARBOXAMIDE METHANESULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
The present invention is 5-chloro-N-({(5S) -2-oxo-3- [4- (5,6-dihydro-4H- [1,2,4] triazin-1-yl) phenyl] A novel crystalline form of -1,3-oxazolidin-5-yl} methyl) thiophene-2-carboxamide methanesulfonate and a pharmaceutical composition comprising the same, wherein the novel crystalline compound according to the present invention has high temperature and humidification. Since it exhibits excellent stability even in the environment, it can be useful for the prevention or treatment of diseases such as thrombosis, myocardial infarction, arteriosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.
展开▼
机译:本发明是5-氯-N-({(5S)-2-氧代-3- [4-(5,6-二氢-4H- [1,2,4]三嗪-1-基)苯基] A -1,3-恶唑烷-5-基甲基)噻吩-2-羧酰胺甲磺酸盐的新结晶形式和包含该结晶形式的药物组合物,其中本发明的新型结晶化合物具有高温和增湿作用。由于即使在环境中也表现出优异的稳定性,因此可用于预防或治疗血栓形成,心肌梗塞,动脉硬化,炎症,中风,心绞痛,血管成形术后再狭窄和血栓栓塞等疾病。
展开▼